Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Sapience Therapeutics brings in $22.5mm through Series A round

Executive Summary

Oncology start-up Sapience Therapeutics Inc. raised $22.5mm in its Series A round. Eshelman Ventures led and was joined by Celgene, TaiAn Technologies, and Healthlink Capital. Maxim Merchant Capital was the placement agent.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies